Solventum Cash Flow from Operating Activities 2023-2025 | SOLV
Solventum annual/quarterly cash flow from operating activities history and growth rate from 2023 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Solventum cash flow from operating activities for the quarter ending March 31, 2025 was $29M, a 93.44% decline year-over-year.
- Solventum cash flow from operating activities for the twelve months ending March 31, 2025 was $2.977B, a 35.28% decline year-over-year.
- Solventum annual cash flow from operating activities for 2024 was $1.185B, a 38.12% decline from 2023.
- Solventum annual cash flow from operating activities for 2023 was $1.915B, a 14.06% increase from 2022.
- Solventum annual cash flow from operating activities for 2022 was $1.679B, a 0% decline from .
| Solventum Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2024 | $1,185 |
| 2023 | $1,915 |
| 2022 | $1,679 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.874B | $8.254B |
| Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.512B | 27.48 |
| Elevance Health (ELV) | United States | $86.065B | 11.11 |
| CVS Health (CVS) | United States | $83.137B | 10.33 |
| Cencora (COR) | United States | $55.558B | 19.33 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.771B | 0.00 |
| BioMerieux (BMXMF) | France | $16.981B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.266B | 0.00 |
| ICON (ICLR) | Ireland | $11.753B | 10.93 |
| CochLear (CHEOY) | Australia | $11.492B | 0.00 |
| Revvity (RVTY) | United States | $11.324B | 19.49 |
| Doximity (DOCS) | United States | $10.794B | 49.97 |
| Viatris (VTRS) | United States | $10.540B | 3.62 |
| Avantor (AVTR) | United States | $9.213B | 13.39 |
| HealthEquity (HQY) | United States | $9.042B | 39.61 |
| Medpace Holdings (MEDP) | United States | $8.689B | 23.08 |
| Sonic Healthcare (SKHHY) | Australia | $8.397B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.422B | 14.54 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.425B | 26.06 |
| BrightSpring Health Services (BTSG) | United States | $3.848B | 35.31 |
| Sotera Health (SHC) | United States | $3.423B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.055B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.969B | 38.62 |
| Concentras Parent (CON) | United States | $2.811B | 16.24 |
| Organon (OGN) | United States | $2.620B | 2.78 |
| GeneDx Holdings (WGS) | United States | $2.006B | 77.28 |
| Ardent Health (ARDT) | United States | $1.908B | 8.13 |
| Progyny (PGNY) | United States | $1.859B | 40.92 |
| Premier (PINC) | United States | $1.853B | 14.06 |
| GoodRx Holdings (GDRX) | United States | $1.618B | 32.36 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.302B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.29 |
| CareDx (CDNA) | United States | $1.118B | 17.46 |
| Establishment Labs Holdings (ESTA) | $1.114B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.844B | 7.90 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.671B | 10.16 |
| Embecta (EMBC) | United States | $0.591B | 3.98 |
| LifeMD (LFMD) | United States | $0.574B | 0.00 |
| Enhabit (EHAB) | United States | $0.519B | 42.71 |
| InnovAge Holding (INNV) | United States | $0.514B | 0.00 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.462B | 10.40 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.255B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.252B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.109B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| OncoCyte (OCX) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| OpGen (OPGN) | United States | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |